To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA)

NCT06487598 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: inj insulin to one group
DRUG: Inj Insulin with Tab Nisha-Amalaki 500 mg twice a day

Sponsor

Hirabai Cowasji Jehangir Medical Research Institute